FRMPD2B: A Potential Drug Target and Biomarker (G728798)

Target Name: FRMPD2B

NCBI ID: G728798

FRMPD2B

FRMPD2B: A Potential Drug Target and Biomarker

FRMPD2B, short for Focal Region Maintenance and PD2-Positive, is a protein that is expressed in various tissues and cells in the body. It is a key regulator of cell adhesion and survival, and is involved in the development and progression of many diseases, including cancer.

One of the most promising aspects of FRMPD2B is its potential as a drug target. Due to its involvement in cell adhesion and survival, scientists and doctors are interested in finding ways to inhibit its activity to treat various diseases.

FRMPD2B has been shown to play a role in the development and progression of many diseases, including cancer. For example, studies have shown that high levels of FRMPD2B are associated with poor prognosis in patients with pancreatic cancer. Additionally, FRMPD2B has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

FRMPD2B is also a potential biomarker for many diseases. Its expression has been shown to be elevated in a variety of diseases, including cancer, and its levels have been used as a biomarker for disease progression. This makes it an attractive target for researchers looking for new diagnostic tools and treatments.

In addition to its potential as a drug target and biomarker, FRMPD2B is also of interest to researchers because of its unique structure and biology. Unlike many other proteins, FRMPD2B is a transmembrane protein, which means that it spans the cell membrane and is involved in processes that occur on both sides of the membrane. This unique structure makes it an interesting target for drugs that can cross the cell membrane and interact with its activity.

FRMPD2B is also a good candidate for a drug because of its ability to interact with other proteins. Studies have shown that FRMPD2B can interact with many different proteins, including the protein PD-L1. This interaction between FRMPD2B and PD-L1 has the potential to make FRMPD2B a good target for drugs that are already being used to treat other diseases, such as cancer.

Overall, FRMPD2B is a protein that is of interest to researchers due to its role in the development and progression of many diseases, its potential as a drug target, and its unique structure and biology. Further research is needed to fully understand its potential and to develop new treatments for various diseases.

Protein Name: FERM And PDZ Domain Containing 2B, Pseudogene

The "FRMPD2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRMPD2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets